UBS raised the firm’s price target on Axon (AXON) to $840 from $820 and keeps a Neutral rating on the shares. Axon’s growth reaccelerated in Q2, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- Axon upgraded to Buy from Hold at Craig-Hallum
- Axon Enterprise’s Strong Growth Potential and Increased Price Target Amid Surpassing Revenue Expectations
- Axon Enterprise’s Strong Financial Performance and Strategic Growth Drive Buy Rating
- Axon Enterprise Reports Strong Q2 2025 Growth
- Axon Enterprise’s Strong Revenue Growth and Bookings Performance Justify Buy Rating and Increased Price Target